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The Lyt-2 and Lyt-3 antigens in the mouse are selectively expressed on a subpop- 
ulation of T  lymphocytes that include the cytotoxic effectors and suppressors  (1-3). 
Two separate alleles of each antigen are known, i.e., Lyt-2.1, Lyt-2.2, Lyt-3.1, and 
Lyt-3.2. Genes controlling the expression of the Lyt-2 and Lyt-3 antigens are closely 
linked to each other on chromosome 6  (4), and are also closely linked to the ~ light 
chain locus (5-7). 
Because of this close association with an immunoglobulin locus and their selective 
expression on functionally distinct subpopulations, the macromolecule(s) carrying the 
Lyt-2 and  Lyt-3 antigens  have  been  thought  to  perform essential  functions,  most 
likely involving cellular interactions or recognition of antigen. Support for this idea 
has come from functional studies of cytotoxic effector T  cells, in which antibodies to 
Lyt-2 or Lyt-3 were shown  to  block killing by binding  to the effector cells  (8,  9). 
Antibodies to Lyt-2 and Lyt-3 also block allogeneic sitmulation of T  cells in mixed 
lymphocyte culture (10,  11). 
It is  important  to understand  the structure of the molecular species carrying the 
Lyt-2 and Lyt-3 antigens in order to analyze its function. The original immunopre- 
cipitation  studies  with  either  Lyt-2  or  Lyt-3  antibodies  from  surface  12SI-labeled 
thymocytes showed  protein(s)  of ~35,000  Mr  under  reducing  conditions  (12).  In 
preclearing experiments (13), it was concluded that Lyt-2 and Lyt-3 antigens reside 
on  separate  molecules,  although  an  association  between  the  two  molecules  was 
apparent. Our recent studies of Lyt-2 from thymocytes using a monoclonal antibody 
and two-dimensional gel electrophoresis run under reducing conditions showed two 
proteins  with  a  basic  charge  and  molecular weights  between  30,000-38,000  (14). 
These two proteins were associated through disulfide bonds into larger forms (65,000- 
75,000 and  140,000 Mr) under nonreducing conditions. 
We show here that Lyt-2 and Lyt-3 antigens are present on individual polypeptide 
subunits that are disulfide-bonded into multimeric forms on the cell surface. We also 
show that  the  Lyt-3 subunit  can  be selectively cleaved from viable cells with  low 
levels of trypsin with a  concommitant but not parallel loss  of cytolytic effector cell 
activity. We use monoclonal antibody blocking of eytotoxie effector cell activity and 
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selective protease removal of Lyt-3 to investigate the role of the Lyt-2, Lyt-3 molecule 
in T  cell recognition of target cell antigens.  Further,  by examining heterozygotes we 
find that  neither Lyt-2 nor Lyt-3 is allelically excluded  in expression  on T  cells.  We 
conclude that the Lyt-2, Lyt-3 molecules are closely associated with but not identical 
to cytolytic T  cell antigen receptors. 
Materials  and Methods 
Antibodies.  Monoclonal rat anti-mouse Lyt-2 (53-6.7) and rat anti-mouse Lyt-3 (53-5) have 
been previously described  (14,  15). Antibodies were purified  from culture supernate on goat 
anti-rat  Ig-Sepharose columns.  Monoclonal anti-Lyt-2.2  (19/178)  was a  kind  gift of Dr.  U. 
H~mmerling, Memorial Sioan-Kettering Cancer Center, New York. This antibody was used as 
serum from hybridoma-bearing mice without further purification. 
Mice.  Young BALB/cNHz mice (6-8 wk) used for the biochemical studies  were bred  at 
Stanford  University,  Stanford,  Calif.  C57BL/6  and  DBA/2  mice  used  for the  cytotoxicity 
studies were obtained from Simonsen Laboratories, Gilroy, Calif. 
Cell Surface Labeling  and Detergent Extraction.  BALB/cNHz thymocytes or lymph node cells 
125T  8  were labeled with  I by a modification of the lactoperoxidase technique. To 1 ×  10  cells in 
1  O  125  1 ml  phosphate-buffered saline  (PBS)  at  20  C  were added  1.0 mCi  I  (Amersham Corp., 
Arlington Heights, Ill.),  25 pg lactoperoxidase (B grade; Calbiochem-Behring Corp., La Jolla, 
Calif.),  and  successive  10-pl pulses of H•O2  (0.3  mM,  1 mM,  3 mM, and  9  mM)  at  5-rain 
intervals. Cells were washed twice in PBS and extracted in lysis buffer (0.5% Nonidet-P40 [NP- 
40, Particle Data Laboratories, Ltd., Elmhurst, Ill.l; 50 mM Tris;  150 mM NaCI; 0.02% NAN3; 
5 mM EDTA; 50 ~M phenylmethylsulfonyl fluoride; 0.2 TIU/ml Aprotinin [Sigma Chemical 
Co., St. Louis, Mo.]; 1 pg/ml pepstatin A [Sigma Chemical Co.]; and 50 mM iodoacetamide, 
pH 8.0) for 30 min at 4°C. Nuclei were removed by eentrifugation at 5,000 g for 20 min. 
Immunoprecipitation and Gel Electrophoresis.  Immunoprecipitations were with -5 pg antibody 
per extract from 2 ×  107 cells. After a  1-h incubation on ice, antigen-antibody complexes were 
collected by the addition of 10 pl of 10% fixed Staphylococcus aureus (staph A) Cowan I strain 
(Tufts New England Enzyme Center, Boston, Mass.).  For the rat antibodies that do not bind 
to protein A directly, the staph A was precoated with affinity-purified mouse (SJL/J) anti-rat 
Ig and  washed  twice before addition  to the cell  extract.  After 45 min on ice,  the staph A- 
antibody-antigen complexes were washed three times in washing buffer (0.5% NP-40, 0.45  M 
NaCI, 50 mM Tris,  5 mM  KI, and 0.02%  NaNa, pH  8.3),  and  then extracted  with  sample 
buffer  for  gel  electrophoresis.  Immunoprecipitates  were  analyzed  either  by  (a)  10%  one- 
dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis  (SDS-PAGE;  16); (b) 
10% SDS-PAGE using N,N'-diallyitartardiamide  (DATD) cross-linked instead of bis-acrylam- 
ide  (17);  or  (c)  two-dimensional  gels  with  a  nonequilibrium  charge  separation  in  the  first 
dimension (18), using a 4:1 ratio ofpH 3.5-10 to pH 8-9.5 ampholines (LKB Western, Pleasant 
Hill, Calif.), and  10% SDS-PAGE in the second dimension. Molecular weight markers (Phar- 
macia Fine Chemicals,  Piscataway, N. J.)  run on each gel  were visualized  by staining with 
Coomassie Brilliant Blue.  Autoradiography was with intensifying screens  (Cronex Lightning- 
plus; DuPont Instruments, Wilmington, Del.)  using Kodak X-Omat R  film (Eastman Kodak 
Co., Rochester, N. Y.) at -70°C. 
T  Cell  Cytotoxicity.  Cytotoxic T  cells were obtained by immunizing C57BL/6 male mice, 
aged  2-3  mo,  with  3  ×  107  P815  (DBA/2 mastocytoma)  cells  intraperitoneally.  P815  was 
carried in vivo by intraperitoneal  injection of 107 cells into DBA/2 mice every 5-10 d.  11  d 
after immunization, spleen cells were used as the source of cytotoxic effectors.  Cytotoxicity was 
assessed against SlCr-labeled P815 target cells, labeled by incubating  107 cells in  100 pCi ~Cr 
in 0.5 ml at 37°C for 1 h. Assays were in round-bottomed microtiter plates (Linbro Chemical 
Co., Hamden, Conn.), using 0.1  ml target cells  (2 ×  10  n cells/ml)  and 0.1  ml spleen effector 
cells  in varying concentration to give spleen cell:target ratios of 100:1,  50:1, 25:1,  12:1, and 
i Abbreviations used in this paper: DATD, diallyltartardiamide;  FACS, fluorescence-activated cell sorter; 
NP-40, Nonidet-P40; PBS, phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide 
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6:1, with triplicate samples of each concentration. The cell  mixture was pelleted by centrifu- 
gation at 100 g for 3 min and incubated for 4 h at 37°C in 5% CO2. After centrifugation at 600 
g  for  10  min,  0.1  ml  of the  supernate  was  removed  for  determination  of 51Cr released. 
Cytotoxicity was determined as previously described (19). Killing is expressed as lytic units per 
107 spleen cells. One lytic unit is defined as the number of spleen cells necessary to specifically 
lyse 40% of the target cells. Triplicate killing curves were derived for each cell  treatment.  For 
trypsinization of effector cells before the assay, spleen cells were collected and washed in PBS 
without  fetal  calf serum,  and 0.5-ml  aliquots containing 2  ×  107 cells  were incubated  with 
varying amounts of trypsin [L(tosylamide-2-phenyl)-ethyl-chloromethyl ketone trypsin; Worth- 
ington Biochemical Corp., Freehold, N. J.]  for 10 min at 37°C. The reaction was stopped by 
the addition of 10 ml PBS containing 10% fetal calf serum. The cells were washed twice and 
then used as effectors. 
Blocking of Cytotoxicity by Monoclonal Antibodies.  Spleen effector cells at 2 ×  107 cells/ml were 
incubated with 20 #g monoclonal antibody for 30 min on ice, followed by the addition of an 
equal volume of medium containing SJL/J anti-rat Ig at  1:25 dilution. After another 30 min 
on ice, the cells were diluted for use as effectors without washing. 
Results 
Specificities  of the Antibodies.  Three  monoclonal  antibodies  that  each  recognize  a 
distinct  Lyt-2  or  Lyt-3  specificity  were  used  in  parallel  studies  for  analysis  of the 
macromolecular antigens.  The reactivities  of the anti-Lyt-2.2  (19/178)  and  the anti° 
Lyt-2  (53-6.7)  antibodies  were  identical  throughout  and  are  consistent  with  a  close 
spatial relationship of the two antigenic determinants.  This was further supported by 
blocking studies,  in which  either  antibody,  if added  initially  to viable  cells,  showed 
complete  blocking  of  the  other  (data  not  shown).  A  third  antibody  (53-5)  was 
identified  as  reacting  with  an  Lyt-3  specificity  based  upon  studies  that  showed 
complete  blocking of its  binding  after  pretreatment  of viable  cells  with  anti-Lyt-3 
alloantibodies  (data  not  shown).  This  latter  antibody  (53-5)  binds  to cells  from all 
strains  examined  so  far,  but  shows  a  >200-fold  higher  affinity  for  Lyt-3.2-bearing 
cells than for Lyt-3.1-bearing cells  (data not shown). 
Characteristics of the Lyt-2, Lyt-3 Macromolecule.  Immunoprecipitations with all three 
antibodies  from NP-40 extracts  of 12SI-labeled thymocytes showed identical  patterns 
on  SDS-PAGE  (Fig.  1).  Under  reducing  gel  conditions,  distinct,  heavily  labeled 
proteins of 34,000 and 38,000 Mr were seen. A  third protein that migrated as a  broad 
FIo.  1.  Immunoprecipitation  of Lyt-2 and Lyt-3 from surface lzSI-labeled BALB/cNHz  thymo- 
cytes. Immunoprecipitated proteins were electrophoresed on 10% polyacrylamide gels in the presence 
of SDS under both reducing and nonreducing conditions. Monoclonal antibodies used for immu- 
noprecipitation  were (1)  anti-Lyt-2.2  (19/178);  (2)  anti-Lyt-2  (53-6.7); (3)  anti-Lyt-3  (53-5); (4) 
anti-T200 (30-G12); (5) background (staph A alone). 1506  STRUCTURE AND  FUNCTION OF Lyt-2,Lyt-3  MACROMOLECULES 
band  at  30,000  Mr was  also specifically precipitated, although this species was  not 
labeled as  heavily as the other two species.  When  analyzed under nonreducing gel 
conditions, each  antibody specifically precipitated proteins of 140,000  and  65,000- 
75,000 Mr. The 65,000-75,000 Mr protein(s) migrated as a  broad band. This band is 
shown  below to be composed of several kinds of dimers of the 30,000,  34,000, and 
38,000 Mr subunits seen under reducing conditions. In some experiments, the 30,000 
Mr  subunit  was  seen under  nonreducing gel conditions  after immunoprecipitation 
with anti-Lyt-3, but not after immunoprecipitation with anti-Lyt-2 (Fig.  2).  Under 
reducing gel conditions, the 30,000 Mr subunit was seen after immunoprecipitation 
with both anti-Lyt-2 and anti-Lyt-3. 
Lyt-2 and Lyt-3 Antigens  Are on the Same Macromolecule.  We used monoclonal anti- 
Lyt-2 and  anti-Lyt-3 antibodies  conjugated on Sepharose to show  that  both  Lyt-2 
and  Lyt-3 antigens  are  on  the  same  macromolecule. A  detergent  lysate  from  125I- 
labeled  thymocytes was  divided  into  three  equal  portions  that  were  (a)  given  no 
treatment, (b) passed through the anti-Lyt-2 absorbent, or (c) passed through the anti- 
Lyt-3 absorbent. Each portion was then subjected to immunoprecipitation with anti- 
Lyt-2.2, anti-Lyt-2, anti-Lyt-3, and  anti-T200  (as  a  control).  The results  (Table I) 
showed that  the anti-Lyt-2 absorbent  removed reactivity with both anti-Lyt-2 and 
anti-Lyt-3 antibodies,  but  not  with  anti-T200.  Similarly,  the anti-Lyt-3 absorbent 
removed  reactivity  with  anti-Lyt-3  but  left  some  reactivity  with  anti-Lyt-2.  Gel 
analysis of the Lyt-2  +, Lyt-3- material showed a 70,000 Mr protein under nonreducing 
conditions that, under reducing conditions, ran as the 38,000 and 34,000 Mr subunits 
(data not shown). These data show that the Lyt-2 and Lyt-3 antigens are co-expressed 
on the same  macromolecules, but  that  a  small  amount  of Lyt-2  +,  Lyt-3- material 
exists in the detergent lysates. 
Lyt-2 and Lyt-3 Antigens Reside on Individual Subunits.  Lyt-2 and Lyt-3 antigens were 
identified on individual subunits by reduction of the molecule in detergent extracts 
(10 mM  dithioerythritol, 3 h, 4°C)  and alkylation  (250 mM  iodoacetamide) before 
immunoprecipitation with  anti-Lyt-2 and  anti-Lyt-3 antibodies.  Both the anti-Lyt- 
2.2 and anti-Lyt-2 immunoprecipitated the 34,000 and 38,000 Mr polypeptides but 
FIG. 2.  Immunoprecipitation  of Lyt-2 and Lyt-3  from surface 12~I-labeled  BALB/cNHz thymo- 
cytes. Immunoprecipitated  proteins  were  electrophoresed  on 10% polyacrylamide  gels in the presence 
of SDS under both reducing and nonreducing  conditions. Monoclonal  antibodies used for immu- 
noprecipitations were (1) anti-Lyt-2.2 (19/178); (2) anti-Lyt-2 (53-6.7); (3) anti-Lyt-3 (53-5); (4) 
background (staph A alone). LEDBETTER,  SEAMAN, TSU,  AND  HERZENBERG 
TABLE  I 
Lyt-2 and Lyt-3 Antigens Are on the Same Macromolecule 
Antibody 
Immunoprecipitation* 
Nontreated  Lyt-2-depteted Lyt-3-depleted 
lysate  lysate:[:  lysate§ 
Anti-Lyt-2 (53-6.7)  23  2.6  6.0 
Anti-Lyt-3 (53-5)  16  4.4  2.8 
Anti-T200 (55-10.2)  76  81  80 
--  2.2  2.6  2.6 
* Number are cpm in the immunoprecipitate (× 10  -a) from surface l~ZI-labeled 
BALB/cNHz thymocyte lysates. 
The  lysate was depleted  of Lyt-2 by passage over an anti-Lyt-2  (53-6.7) 
antibody-Sepharose column. 
§The  lysate was  depleted  of Lyt-3  by passage over  an  anti-Lyt-3  (53-5) 
antibody-Sepharose column. 
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FIG.  3.  Immunoprecipitation  of anti-Lyt-2 and anti-Lyt-3 from surface 12~I-labeled BALB/cNHz 
thymocytes after reduction  and alkylation of the  detergent  lysate. Immunoprecipitated  proteins 
were electrophoresed on 10% polyacrylamide gels in the presence of SDS under both reducing and 
nonreducing conditions. Lanes 1-4 are immunoprecipitated  proteins from reduced and alkylated 
detergent lysate using monoclonal antibodies: (1) anti-Lyt-2.2 (19/178); (2) anti-Lyt-2 (53-6.7); (3) 
anti-Lyt-3 (53-5); and (4) background (staph A alone). Lanes 5-8 are immunoprecipitated proteins 
from an alkylated but not reduced detergent lysate using monoclonal antibodies: (5) anti-Lyt-2.2 
(19/178); (6) anti-Lyt-2 (53-6.7); (7) anti-Lyt-3 (53-5); and (8) background (staph A alone). 
not  the  30,000  Mr  polypeptide,  whereas  the  anti-Lyt-3  antibody  reacted  with  the 
30,000 Mr polypeptide but not the 34,000 or 38,000 Mr polypeptides  (Fig.  3).  These 
patterns  of reactivity  were  the  same  whether  the  gels were  run  under  reducing  or 
nonreducing  conditions,  indicating  that  the  initial  reduction  of the  cell  lysate was 
complete. Therefore, the Lyt-3 antigenic determinant  (as identified by rat monoclonal 
antibody 53-5)  is on the 30,000 M~ subunit,  whereas  the Lyt-2.2 and Lyt-2 antigenic 
determinants  (as  identified  by monoclonal  antibodies  19/178  and  53-6.7)  reside  on 
either  the  34,000 or 38,000  Mr subunits  or both.  As noted  above,  small  amounts of 
Lyt-2  +,  Lyt-3- material  was identified  using immunoadsorbent  columns.  Similarly, 
some immunoprecipitation  experiments revealed small amounts of free Lyt-3 subunit 
(30,000 Mr)  in nonreduced detergent  lysates  (Fig. 2). 
Subunit Composition  of the Lyt-2,Lyt-3 Macromolecule.  "lZwo-dimensional SDS-PAGE of 
the  Lyt-2,Lyt-3 macromolecule  provided  additional  information  about  the  subunit 
composition. An anti-Lyt-2 immunoprecipitate was electrophoresed under nonreduc- 1508  STRUCTURE  AND FUNCTION OF  Lyt-2,Lyt-3 MACROMOLECULES 
ing conditions on  10% DATD cross-linked SDS tube gels, followed by electrophoresis 
in  the  second  dimension  under  reducing  conditions  on  12.5%  bisacrylamide-acryl- 
amide slab gels (Fig. 4). This analysis showed that the  140,000-Mr species seen under 
nonreducing conditions is composed of all three of the 38,000, 34,000, and 30,000 Mr 
subunits.  A  larger  macromolecule  (>200,000  Mr)  also  reduced  to  the  same  three 
subunits, whereas the 65,000-75,000-Mr  material was composed of at least two kinds 
of molecules, including  dimers of (a)  the  38,000  and  30,000  Mr species, and  (b)  the 
34,000  and  30,000  Mr  species.  The  existence  of 34,000-34,000,  38,000-38,000,  and 
38,000-34,000  Mr  dimers  is  not  proven  or  disproven  in  Fig.  4.  However,  the  Lyt- 
2+,Lyt-3  -  material identified  by use of immunoadsorbent columns  (see above) con- 
sisted of only 38,000-34,000  Mr dimers and not  38,000-38,000  or 34,000-34,000  Mr 
dimers. Therefore, three of the six possible dimeric combinations of the 38,000, 34,000, 
and  30,000  Mr  subunits  have  been  positively  identified.  Interestingly,  these  three 
combinations are all heterodimers (dimers of nonidentical subunits). 
Two-Dimensional  (Charge  vs.  Size)  Separation of Lyt-2,Lyt-3  Macromolecules from  Thymo- 
cytes.  Two-dimensional  gels  of  an  Lyt-2  immunoprecipitate  run  under  reducing 
conditions  showed  that  the  three subunits  run  with  very basic charges  (Fig.  5).The 
Lyt-3 subunit  (30,000  Mr)  is the most basic species and was not seen in earlier two- 
dimensional gel experiments (14)  where it had migrated off the basic end of the gel. 
The Lyt-2 subunits  (34,000 and 38,000 Mr) were also very basic. Under nonreducing 
conditions, the 65,000-75,000  Mr material clearly separated into two species, with the 
higher  molecular  weight  species  migrating  with  a  more  acidic  charge  (Fig.  5). 
Similarly, the  140,000 and 200,000  Mr species showed a  more acidic charge than any 
of the three individual subunits. This result may be attributed to (a) the macromole- 
cule,  because  it  is  composed  of disulfide-bonded  subunits,  may  retain  some of its 
conformation under nonreducing conditions that mask some of the basic charge of its 
subunits;  or (b) yet another subunit exists as part of the macromolecule that has not 
been identified because it does not  label with  125I-lactoperoxidase on viable cells;  or 
FIG. 4.  Two-dimensional  ~el electrophoresis of the Lyt-2,Lyt-3  macromolecule.  A detergent lysate 
from BALB/cNHz surface lZ~l-labeled  thymocytes  was immuooprecipitated  with anti-Lyt-2 (53-6.7) 
and electrophoresed  under nonreducing gel conditions in the first dimension and under reducing gel 
conditions in the second dimension. The first dimension tube gels were 10% DATD-acrylamide  and 
the second dimension slab gels were 12.,5% bisacrylamide-acrylamide.  The top of the figure shows 
a  gel  track  of an  anti-Lyt-2 immunoprecipitate run  on  a  10%  DATD-acrylamide gel  under 
nonreducing conditions. LEDBETTER,  SEAMAN,  TSU,  AND HERZENBERG  1509 
FI6.  5.  Two-dimensional gel electrophoresis of the Lyt-2, Lyt-3 macromolecule. A detergent lysate 
from BALB/cNHz surface  12hi-labeled thymocytes  was immunoprecipitated  with  anti-Lyt-2  (53- 
6.7). The first dimension was a charge separation with the acidic side on the right and the basic side 
on  the  left. The second  dimension  was  10% SDS-polyacrylamide  slab  gels from  the  top  to  the 
bottom. A, nonreducing;  B, reducing. 
(c)  the  larger  multimeric  forms have more carbohydrate  and  are more acidic  due  to 
additional  sialic acid residues. 
Immunoprecipitation  with anti-Lyt-2 from 125I-lactoperoxidase-labeled lymph node 
cells showed  some differences  in  the  structure  of the  macromolecule  compared  with 
thymocytes.  Under  reducing  conditions  on  SDS  gels,  the  30,000  Mr species  that  by 
analogy  with  thymocytes  corresponds  to  the  Lyt-3  subunit  was  present.  However, 
instead  of the  34,000  and  38,000  Mr  species  seen  on  thymocytes,  only  a  protein  of 
38,000  Mr  was  seen  on  lymph  node  cells.  Although  this  latter  38,000  Mr  species 
migrated  as a  tight  double  band,  the  34,000  Mr species seen on  thymoctyes was not 
present  on lymph node cells  (results  not  shown).  These results suggest  that  the Lyt-2 
subunit  is processed differently in thymus vs. lymph node. 
The Lyt-2,Lyt-3 Macromolecule Does Not Show Allelic Exclusion.  Because of the close 
genetic association of Lyt-2 and Lyt-3 genes with i¢ light chain loci and the haplotype 
exclusion  demonstrated  by K light chains,  it was of interest  to determine  whether  the 
expression  of Lyt-2  and  Lyt-3 antigens  is  regulated  in  a  similar  way,  i.e.,  by allelic 
exclusion.  Quantitative  immunofluorescence  of  (BALB/cNHz  X  AKR/J)F1  mice 
(Lyt-2  a/b,  Lyt-3  a/b)  thymocytes  and  spleen  cells  compared  with  each  parental  strain 1510  STRUCTURE AND FUNCTION OF  Lyt-2,Lyt-3  MACROMOLECULES 
showed  that  Lyt-2.2  and  Lyt-3.1  do  not  show  allelic exclusion  on  thymocytes  or T 
cells  (Table  II).  In the heterozygote,  the antigens  are  found  on  the same percentage 
of cells as the positive parental  strain, but are expressed  in lower density than on cells 
from the positive parental  strains. 
Trypsin  Sensitivity of Lyt-2 and Lyt-3 Antigens on  Viable  Cells.  Both  Lyt-2  and  Lyt-3 
antigens  are efficiently digested  from  viable cells with  low levels of trypsin,  whereas 
Lyt-1  is  not  removed  under  these  conditions.  Fig.  6  shows  that  Lyt-2  and  Lyt-3 
antigens  on  thymocytes  exhibit  differential  sensitivity  to  trypsin.  Lyt-3  antigens  are 
TABLE  II 
Lyt-2 and Lyt-3 Do Not Show Allelic Exclusion 
FACS analysis* 
Thymus  Spleen 
Mouse strain (Lyt-2,Lyt-3  Lyt-2.2:[:  Lyt-3.1§  Lyt-2.2:[:  Lyt-3.1§ 
phenotype) 
Mean  Mean  Mean  Mean 
of posi-  % pos-  % pos-  % pos-  % pos-  itive  of posi-  . .  of posi-  .  of posi-  rove  it]ve  itive  tivell  tive  tive  tire 
AKR/J (Lyt-2.t,3.1)  --  <1  380  89  --  <1  420  13 
BALB/cNHz (Lyt-2.2,3.2)  410  85  --  <1  467  14  --  <1 
(AKR/J ×  BALB/cNHz)F~  240  86  210  84  257  13  238  12 
* Immunofluoreseence staining was analyzed using a fluorescence-activated cell sorter (FACS)-II (Becton 
Dickinson  FACS Division, Sunnyvale, Calif.). 
:~ Immunofluorescence staining with anti-Lyt-2.2  (19/178)  was done indirectly using a  fluorescein-conju- 
gated goat anti-mouse IgG2 second-step  antibody. 
§ Immunofluorescence staining  with  anti-Lyt-3.1  [E2(7)]  was  done  indirectly  using  biotin-conjugated 
antibody followed  by fluorescein-conjugated avidin second-step  reagent. The anti-Lyt-3.1  monoclonal 
antibody [E2(7)] was a gift from Dr. P. Gottlieb, University of Texas, Austin, Tex. 
]1 Geometric mean fluorescence  of positive cells is expressed  in arbitrary linear units. 
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FIG. 6.  Trypsin digestion of BALB/cNHz thymocytes.  The cells (4 ×  107/ml) were digested with 
the indicated amount of trypsin for 10 min at 37°C. The digestion  was stopped by the addition of 
10 ml of medium containing 15% calf serum.  Cells were then stained with fluorescein-conjugated 
anti-Lyt-I (53-7.3), fluorescein-conjugated anti-Lyt-2 (53-6.7), and fluoreseein-conjugated anti-Lyt- 
3 (53-5). The percentage of specific staining was calculated by: 
(Fluorescence  intensity at "X" trypsin)  -  (background fluorescence  [unstained cells]) ×  100. 
(Fluorescence  intensity at "O" trypsin)  -  (background fluorescence  [unstained cells]) LEDBETTER,  SEAMAN,  TSU,  AND  HERZENBERG  1511 
cleaved more readily than Lyt-2 antigens and can be almost completely removed with 
>60% of Lyt-2 antigens remaining  (Fig.  6). Although the data shown were derived 
from assays using monoclonal antibodies, similar results were obtained using conven- 
tional  anti-Lyt alloantisera  from several sources (data not shown). The differential 
trypsin sensitivity of Lyt-2 and Lyt-3 confirms the work of Durda and Gottlieb (13). 
We also observed differential  trypsin  sensitivity of Lyt-2 and  Lyt-3 on  peripheral 
(spleen  and  lymph  node)  T  ceils  (data  not  shown).  Studies  with  other,  arginine- 
specific, proteases (clostridium protease, Staphylococcus aureus V8 protease) indicate that 
the differential sensitivity of Lyt-2 and  Lyt-3 reflects cleavages at  arginine-specific 
sites (data not shown). 
Role of the Lyt-2,Lyt-3 Macromolecule  on Cytotoxic  T cells.  Cytotoxic T cells generated 
in vivo against P815 mastocytoma cells were assayed for activity against 5~Cr-labeled 
P815 in efforts to examine the role of the Lyt-2,Lyt-3 macromolecule in the killing 
process. We took advantage of the selective trypsin cleavage of the Lyt-3 subunit and 
the ability to measure residual Lyt-2 and Lyt-3 antigens on the killer population by 
quantitative  fluorescence  to  examine  the  relationship  of cytotoxic activity  to  the 
amount of Lyt-2 and Lyt-3 antigens remaining.  The results (Table III) showed that 
the loss of cytotoxic activity after trypsin treatment did not quantitatively parallel the 
TABLE  III 
Effect of T~ypsin Treatment on Blocking of Cytotoxic Effector Cells with Anti-Lyt-2 and Anti-Lyt-3 
Blocking antibody§ 
Surface  Surface  Lytic unitsll  P¶  Blocking 
Trypsin*  Lyt-2:~  Lyt-3:]:  Anti-  Monoclonal  (±SEM) 
rat Ig  rat antibody 
%  % 
Experiment  1 
0  100  100 
25 ~g  76  <5 
Experiment 2 
0  100  100 
25 p,g  84  <5 
-  --  60  (+2)  -- 
+  --  62 (-1-4)  NS** 
+  Anti-Lyt-1  64 (± 11)  NS 
+  Anti-Lyt-2  40 (± l)  <0.005  35 
+  Anti-Lyt-3  21  (±1)  <0.005  66 
--  --  45  (±2) 
+  --  45 (±2)  NS 
+  Anti-Lyt- 1  48 (±3)  NS 
+  Anti-Lyt-2  22 (±3)  <0.003  51 
+  Anti-Lyt-3  33 (±2)  <0.01  27 
+  --  27 (+2) 
+  Anti-Lyt-2  14 (±1)  <0.003  48 
+  Anti-Lyt-3  9 (±1)  <0.00I  67 
+  --  21  (±1) 
+  Anti-Lyt-2  <5  <0.001  >76 
+  Anti-Lyt-3  13 (±2)  <0.01  38 
* Cytotoxic effector cells at 2 ×  107 cells/0.5 ml were treated with the indicated amount of trypsin for  10 
rain at 37°C. 
:~ Cells were assayed for surface Lyt-2 and Lyt-3 using fiuorescein-conjugated 53-6.7 and 53-5 monoclonal 
antibodies and a  FACS-II. 
§ Blocking ofT cell killing is described in Materials and Methods. 
II Lytic units were calculated as described in Materials and Methods. 
¶ Significance levels calculated with the Student's t test. 
** Not significant. 1512  STRUCTURE  AND  FUNCTION  OF  Lyt-2,Lyt-3  MACROMOLECULES 
loss  of Lyt-3 antigens  on  the  cytotoxic T  cell  population.  After  almost  complete 
removal of Lyt-3, the cytolytic activity had decreased by -25%.  These assays were 
repeated several times with similar results.  Using a  cytotoxic T  cell line (L3C5;  20) 
rather than in vivo-generated cytotoxic T  cells, we found the opposite results; the loss 
of cytolytic activity after trypsin treatment was  more rapid  than  the loss  of Lyt-3 
antigen (A. Glasebrook, J. A. Ledbetter, and L. A. Herzenberg, unpublished data). In 
neither case, however, was an exact quantitative correlation seen between cleavage of 
Lyt-3 and loss of cytolytic activity. 
Table III shows that after trypsin treatment, the in vivo-generated cytotoxic effector 
cells could still kill, and that  the blocking of killing by anti-Lyt-3 was significantly 
reduced, whereas  the blocking of killing by anti-Lyt-2 was  significantly improved. 
Although  Lyt-3 was  not  detected by  immunofluorescence after trypsin  treatment, 
some blocking of killing by anti-Lyt-3 was still observed  (Table III). The blocking 
assay may be more sensitive than immunofluorescence for detection of low levels of 
surface Lyt-3. The results imply that killer T  ceils with very low levels of the Lyt-3 
subunit are still functional, and that the activity of the Lyt-2,Lyt-3 molecule relevant 
to the killing process may not reside in the Lyt-3 subunit. 
Discussion 
Lyt-2 and Lyt-3 antigens are controlled by closely linked genes (4). The results of 
this paper show that  Lyt-2 and Lyt-3 antigens are part of the same macromolecule 
and that they reside on different subunits. This is unlike the situation with some other 
multimeric molecules such as hemoglobins, immunoglobulins, and H-2 (K or D with 
B2 microglobulin), in which genes controlling individual subunits are not linked. In 
other multimeric proteins, such as insulin or the murine leukemia virus envelope gene 
products, the individual subunits are both coded for by a  single gene. This leads to 
production  of a  precursor  polyprotein,  which  is  processed  post-translationally  by 
proteolytic cleavage to generate the separate subunits. 
Our findings, together with the previously known close linkage of Lyt-2 and Lyt-3, 
suggest  that  the  biosynthesis of Lyt-2 and  Lyt-3 subunits  may proceed through  a 
precursor  polyprotein  intermediate.  Pulse-chase  labeling  studies  could  determine 
whether Lyt-2 and Lyt-3 subunits are synthesized as a polyprotein that is subsequently 
cleaved. 
When analyzed under nonreducing gel conditions, the Lyt-2,Lyt-3 macromolecules 
are seen in a variety of multimeric forms. Because the antigen densities of Lyt-2 and 
Lyt-3 measured on thymocytes or T  cells are equal (15), the various multimeric forms 
appear to be hexamers, tetramers, and dimers consisting of equal numbers of Lyt-2 
and Lyt-3 subunits. The biochemical analyses (immunoprecipitation and gel electro- 
phoresis)  reported  here  are  performed rapidly  in  the  cold and  in  the  presence of 
protease inhibitors and alkylating reagents, so it is likely that the various multimeric 
forms  of  the  macromolecule  are  present  on  the  cell  surface  rather  than  being 
artifactually produced during the isolation procedure. 
In addition to the Lyt-2,Lyt-3 multimers, we found small amounts of the monomer 
Lyt-3 subunit  (30,000 Mr)  in detergent lysates of labeled cells.  Some Lyt-2+Lyt-3  - 
material was present also, in the form of dimers of the 34,000 and 38,000 Mr subunits. 
These results are qualitatively consistent with the experiments of Durda and Gottlieb 
(13),  who  did  similar  anti-Lyt-2  and  anti-Lyt-3  preclearing  experiments.  These LEDBETFER, SEAMAN, TSU, AND HERZENBERG  1513 
workers concluded that Lyt-2 and Lyt-3 antigens are separable. We find that the free 
Lyt-3 and  Lyt-2 subunits  are  minor species  in  the  detergent  lysates, whereas  the 
multimeric Lyt-2,Lyt-3 forms account for almost all of the antigenic protein. 
The  one-  and  two-dimensional gel  patterns  that  we  obtain  for the  Lyt-2,Lyt-3 
maeromolecule are very similar to those of Reilly et al. (20). These authors identified 
two heavily labeled subunits of 35,000 and 30,000  Mr and a  faintly labeled subunit 
of <30,000 Mr. Based on their charge and labeling properties, these subunits corre- 
spond to the 38,000,  34,000, and 30,000  Mr subunits seen in our experiments. The 
differences in apparent molecular weight most likely result from differences in the gel 
systems used. 
Our demonstration that Lyt-2 and Lyt-3 antigens reside on separate subunits relied 
on the retention of antigenic activity after reduction and alkylation in the cold of the 
NP-40  cell  lysate.  In  these  experiments  using  labeled  thymocytes, the  30,000  Mr 
subunit  specifically  reacted  with  anti-Lyt-3,  whereas  the  34,000  and  38,000  Mr 
subunits specifically reacted with anti-Lyt-2. It is most likely that these latter two 
subunits both have Lyt-2 antigenic determinants and arise from a post-translational 
processing  difference  involving either  carbohydrate  or  proteolytic  cleavage.  This 
interpretation is supported by the observation that only one of the Lyt-2 subunits 
(38,000  Mr) was seen on lymph node T cells. Alternatively, there is the possibility that 
only one of the two species that coprecipitated with anti-Lyt-2 from thymocytes has 
the  Lyt-2  determinants,  whereas  the  other  is  tightly  associated  through  strong 
noncovalent interactions. 
Lyt-2 and  Lyt-3 antigens on  viable  cells show differential sensitivity to  trypsin 
cleavage. Lyt-3 antigens can be almost completely removed under conditions in which 
Lyt-2 antigens are only slightly affected. Our studies of in vivo-generated T killer cells 
after trypsin treatment suggest that the Lyt-3 subunit is not required for cytolytic 
activity. This conclusion derives from the observation that trypsin-treated cytotoxic 
T  cells with <5%  residual  Lyt-3 retain >75%  of their cytolytic activity. However, 
some blocking of killing with anti-Lyt-3 still occurs. Because these experiments were 
performed  with  in  vivo-generated  cytotoxic T  cells,  the  effector cells  represent  a 
heterogeneous population of T  cell clones. Similar studies with a cytotoxic T  cell line 
(L3C5; 21) showed that the lyric activity was more sensitive to trypsin than was the 
Lyt-3 subunit. If the Lyt-3 subunit had been directly involved in antigen recognition, 
we would have seen parallel losses of the antigen and cytolytic activity. 
The loci controlling Lyt-2 and Lyt-3 are closely linked ~o the mouse x chain genes 
on  chromosome 6  (5-7).  Although this  close  linkage may be  fortuitous, it  is  also 
possible that V, gene products associate with the Lyt-2,Lyt-3 macromolecule. How- 
ever, control of expression of these linked genes may be different because Lyt-2 and 
Lyt-3 are not allelically excluded (on T  ceils),  whereas V,  (on B cells)  is allelically 
excluded. Some evidence for light chain variable region  (Vx) expression on T  cells 
bearing  the  Lyt-2,Lyt-3 antigens  is  available  (22),  but  whether  Vx  is  allelically 
excluded on these cells is not known. 
Comparative structural and functional studies of mouse and human T cell antigens 
have shown that human cytotoxic/suppressor T  cells have a molecule homologous to 
the  mouse  Lyt-2,Lyt-3  molecule  (23,  24).  This  human  molecule  was  originally 
recognized by the heteroantisera used to define the TH2  + T  cell subset (25) and has 
now been characterized by monoclonal antibodies T5  (26),  and SK1  and SK2 (23, 1514  STRUCTURE  AND FUNCTION OF  Lyt-2,Lyt-3 MACROMOLECULES 
24).  The human Lyt-2,Lyt-3 homologue, termed Leu-2, parallels the mouse antigen 
in  its  selective  expression  on  a  functional  subset  of T  cells  and  its  structure  as  a 
multimeric  macromolecule composed of individual  disulfide-bonded  subunits  (23). 
Furthermore, the anti-Leu-2 monoclonal antibodies (SK1 and SK2) parallel the anti- 
Lyt-2 and anti-Lyt-3 antibodies in the blocking of killing by human cytotoxic T  cells 
in the absence of complement (24). 
The maintenance of homologous molecules on functionally distinct T  cell subpop- 
ulations in two evolutionarily distant species suggests that the Lyt and Leu antigens 
perform essential  functions  for the cells on which  they are found.  The data  so far, 
including  (a)  lack of allelic exclusion, and  (b) nonparallel losses of the Lyt-3 subunit 
with T  cell cytolytic activity after trypsin treatment, suggest that this role is something 
other than that of a direct antigen receptor. 
Summary 
Lyt-2 and Lyt-3 antigens are carried on separate disulfide-bonded subunits of the 
same cell surface macromolecules.  These are present  on  thymocytes in  a  variety of 
multimeric forms consisting of disulfide-bonded  dimers, tetramers, and hexamers of 
pairwise  combinations  of  three  subunits  (30,000,  34,000,  and  38,000  Mr).  From 
reduced and alkylated Nonidet-P40 thymus extracts, a monoclonal anti-Lyt-3 precip- 
itates only the 30,000  Mr subunit,  whereas monoclonal anti-Lyt-2 antibody precipi- 
tates both the 38,000 and 34,000 Mr subunits, but not the 30,000 M~ subunit. Almost 
all of the Lyt-2 and Lyt-3 subunits on the cell are covalently linked by disulfide bonds. 
However, small  amounts  of the  free  Lyt-3 subunit  was  seen  in  some experiments. 
Similarly, small amounts of Lyt-2+3  -  material, consisting of dimers of the 38,000 and 
34,000 Mr subunits were identified. Each of the three subunits migrated with a basic 
charge (pI >  8)  on two-dimensional gels. 
Cytotoxic effector cells that are blocked by anti-Lyt-2 and anti-Lyt-3 can be treated 
with  trypsin and other arginine-specific proteases to remove these antigens.  At  low 
concentrations of these proteases, Lyt-3 antigens are selectively removed. After selec- 
tive removal of Lyt-3 antigens, cytotoxic effector cells are still active and blocking of 
activity by anti-Lyt-3 is significantly reduced,  whereas blocking of activity by anti- 
Lyt-2  is  significantly  increased.  Neither  Lyt-2  nor  Lyt-3  is  allelically  excluded  on 
thymocytes or T  cells. These results suggest that the Lyt-2,Lyt-3 macromolecules are 
associated with but do not serve as the T  cell antigen receptor. 
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